EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical
Services, Inc. (NYSE: WST), a global leader in innovative solutions
for injectable drug administration, today announced that it has
received the 2018 Excellence in Pharma: Corporate Social
Responsibility Award. The honor was presented to West on
October 9, 2018, at the CPhI
Worldwide conference in Madrid,
Spain.
Organized by CPhI Worldwide, one of the world's largest pharma
trade shows, the CPhI Pharma Awards recognize innovative
pharmaceutical companies who are committed to driving the industry
forward. The Excellence in Pharma: Corporate Social Responsibility
Award highlights innovation in improving transparency and public
outreach, while also recognizing new programs in charitable work;
sustainability and environmental protection; employee reward, fair
pay and ethical working policies; and training
programs.
"The CPhI Excellence in Pharma Awards are among the most
prestigious awards within the pharmaceutical industry," said
Steve Walton, West's Vice President,
HSE & Sustainability. "It is an honor to be recognized by CPhI
Worldwide, which underscores our commitment to caring for our
environment, which has long been a defining characteristic of West.
We strive to be stewards of a sustainable future by factoring
environmental considerations into our decision making, from the raw
materials we use, to our manufacturing techniques and all the way
through to our packaging and distribution methods. We are proud of
the progress we have made and are committed to making an even
bigger impact in the future."
West has six key areas of Corporate Responsibility focus –
Compliance and Ethics, Philanthropy, Diversity, Health and Safety,
Environmental Sustainability and Quality. In 2017, the Company
surpassed its 2020 goals for both emissions and water reduction;
achieved an all-time low for employee workplace safety incidents;
and continued its long-time philanthropic activities. In 2017,
Corporate and Foundation giving reached over $1.8 million, and team member giving totaled
nearly $530,000. Since the inception
of the Company's primary philanthropic organization in 2004, West
without Borders, West employees have raised and donated millions of
dollars for a variety of charities located around the globe through
this and other programs.
For more information about West and our commitment to Corporate Responsibility, please visit us online at
www.westpharma.com.
For more information about the CPhI Pharma Awards, please visit
https://awards.cphi.com.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2017 net
sales of $1.6 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world.
West and the diamond logo are registered trademarks of West
Pharmaceutical Services, Inc., in the
United States and other jurisdictions.
West without Borders is not affiliated with Doctors Without
Borders®, which is a registered service mark of
Bureau International de Médecins San
Frontières.
Media Contact:
Eric
Haman
Director, Global Corporate Communications
+1-610-594-3440
Eric.Haman@westpharma.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/west-receives-excellence-in-pharma-corporate-social-responsibility-award-at-cphi-worldwide-300729021.html
SOURCE West Pharmaceutical Services, Inc.